n/a
Article Publish Status: FREE
Abstract Title:

Vitamin C promotes ACE2 degradation and protects against SARS-CoV-2 infection.

Abstract Source:

EMBO Rep. 2023 Apr 5 ;24(4):e56374. Epub 2023 Mar 6. PMID: 36876523

Abstract Author(s):

Yibo Zuo, Zhijin Zheng, Yingkang Huang, Jiuyi He, Lichao Zang, Tengfei Ren, Xinhua Cao, Ying Miao, Yukang Yuan, Yanli Liu, Feng Ma, Jianfeng Dai, Sheng Tian, Qiang Ding, Hui Zheng

Article Affiliation:

Yibo Zuo

Abstract:

ACE2 is a major receptor for cellular entry of SARS-CoV-2. Despite advances in targeting ACE2 to inhibit SARS-CoV-2 binding, strategies to flexibly and sufficiently reduce ACE2 levels for the prevention of SARS-CoV-2 infection have not been explored. Here, we reveal vitamin C (VitC) administration as a potent strategy to prevent SARS-CoV-2 infection. VitC reduces ACE2 protein levels in a dose-dependent manner, while even a partial reduction in ACE2 levels can greatly inhibit SARS-CoV-2 infection. Further studies reveal that USP50 is a crucial regulator of ACE2 levels. VitC blocks the USP50-ACE2 interaction, thus promoting K48-linked polyubiquitination of ACE2 at Lys788 and subsequent degradation of ACE2 without affecting its transcriptional expression. Importantly, VitC administration reduces host ACE2 levels and greatly blocks SARS-CoV-2 infection in mice. This study reveals that ACE2 protein levels are down-regulated by an essential nutrient, VitC, thereby enhancing protection against infection of SARS-CoV-2 and its variants.

Study Type : Animal Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.